The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single Cell Analysis.

IF 4 2区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
STEM CELLS Pub Date : 2023-03-02 DOI:10.1093/stmcls/sxac088
Haoteng Yan, Jiali Zhu, Yanyan Ping, Min Yan, Gaoming Liao, Huating Yuan, Yao Zhou, Fengyu Xiang, Bo Pang, Jinyuan Xu, Lin Pang
{"title":"The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single Cell Analysis.","authors":"Haoteng Yan,&nbsp;Jiali Zhu,&nbsp;Yanyan Ping,&nbsp;Min Yan,&nbsp;Gaoming Liao,&nbsp;Huating Yuan,&nbsp;Yao Zhou,&nbsp;Fengyu Xiang,&nbsp;Bo Pang,&nbsp;Jinyuan Xu,&nbsp;Lin Pang","doi":"10.1093/stmcls/sxac088","DOIUrl":null,"url":null,"abstract":"<p><p>Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the importance of the cellular states of primary GSCs. In this study, we leveraged single-cell transcriptome sequencing data of 6 independent GBM cohorts from public databases, and combined lineage and stemness features to identify primary GSCs. We dissected the cell states of GSCs and correlated them with the clinical outcomes of patients. As a result, we constructed a cellular hierarchy where GSCs resided at the center. In addition, we identified and characterized 2 different and recurrent GSCs subpopulations: proliferative GSCs (pGSCs) and quiescent GSCs (qGSCs). The pGSCs showed high cell cycle activity, indicating rapid cell division, while qGSCs showed a quiescent state. Then we traced the processes of tumor development by pseudo-time analysis and tumor phylogeny, and found that GSCs accumulated throughout the whole tumor development period. During the process, pGSCs mainly contributed to the early stage and qGSCs were enriched in the later stage. Finally, we constructed an 8-gene prognostic signature reflecting pGSCs activity and found that patients whose tumors were enriched for the pGSC signature had poor clinical outcomes. Our study highlights the primary GSCs heterogeneity and its correlation to tumor development and clinical outcomes, providing the potential targets for GBM treatment.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":"41 2","pages":"111-125"},"PeriodicalIF":4.0000,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"STEM CELLS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/stmcls/sxac088","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the importance of the cellular states of primary GSCs. In this study, we leveraged single-cell transcriptome sequencing data of 6 independent GBM cohorts from public databases, and combined lineage and stemness features to identify primary GSCs. We dissected the cell states of GSCs and correlated them with the clinical outcomes of patients. As a result, we constructed a cellular hierarchy where GSCs resided at the center. In addition, we identified and characterized 2 different and recurrent GSCs subpopulations: proliferative GSCs (pGSCs) and quiescent GSCs (qGSCs). The pGSCs showed high cell cycle activity, indicating rapid cell division, while qGSCs showed a quiescent state. Then we traced the processes of tumor development by pseudo-time analysis and tumor phylogeny, and found that GSCs accumulated throughout the whole tumor development period. During the process, pGSCs mainly contributed to the early stage and qGSCs were enriched in the later stage. Finally, we constructed an 8-gene prognostic signature reflecting pGSCs activity and found that patients whose tumors were enriched for the pGSC signature had poor clinical outcomes. Our study highlights the primary GSCs heterogeneity and its correlation to tumor development and clinical outcomes, providing the potential targets for GBM treatment.

单细胞分析揭示胶质母细胞瘤干细胞的异质性细胞状态。
胶质母细胞瘤干细胞(GSCs)促进了胶质母细胞瘤(GBM)的进展、治疗耐药性和复发。然而,目前对GSCs的研究通常是在人肿瘤微环境之外进行的,忽视了原代GSCs细胞状态的重要性。在这项研究中,我们利用来自公共数据库的6个独立GBM队列的单细胞转录组测序数据,并结合谱系和干性特征来鉴定原代GSCs。我们解剖了GSCs的细胞状态,并将它们与患者的临床结果联系起来。因此,我们构建了一个以GSCs为中心的细胞层次结构。此外,我们鉴定并表征了2种不同的复发性GSCs亚群:增殖性GSCs (pGSCs)和静止性GSCs (qGSCs)。pGSCs表现出高的细胞周期活性,表明细胞分裂速度快,而qGSCs则处于静止状态。然后,我们通过伪时间分析和肿瘤系统发育来追踪肿瘤的发展过程,发现GSCs在整个肿瘤发展时期都有积累。在此过程中,pGSCs主要参与早期,qGSCs在后期富集。最后,我们构建了一个反映pGSC活性的8基因预后标记,发现富含pGSC标记的肿瘤患者的临床结果较差。我们的研究强调了原发性GSCs的异质性及其与肿瘤发展和临床结果的相关性,为GBM治疗提供了潜在的靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
STEM CELLS
STEM CELLS 医学-生物工程与应用微生物
CiteScore
10.30
自引率
1.90%
发文量
104
审稿时长
3 months
期刊介绍: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology. STEM CELLS covers: Cancer Stem Cells, Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells, Regenerative Medicine, Stem Cell Technology: Epigenetics, Genomics, Proteomics, and Metabonomics, Tissue-Specific Stem Cells, Translational and Clinical Research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信